Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia.

Xu, Xuezhu; Liu, Rui; He, Aili; Wang, Fangxia

Xu, Xuezhu; Liu, Rui; He, Aili; Wang, Fangxia.

Afiliação

Xu X; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Liu R; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
He A; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Wang F; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.

Hematology ; 28(1): 2265206, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37796109

Assuntos

Antineoplásicos; Leucemia Mieloide Aguda; Humanos; Adulto Jovem; Estudos Retrospectivos; Antineoplásicos/uso terapêutico; Compostos Bicíclicos Heterocíclicos com Pontes/efeitos adversos; Leucemia Mieloide Aguda/patologia; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos

Palavras-chave

Acute myeloid leukemia; allogeneic hematopoietic stem cell transplantation; azacytidine; hypomethylating agents; refractory; relapsed; venetoclax; young patients

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antineoplásicos Limite: Adult / Humans Idioma: En Revista: Hematology Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google